Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
ConclusionsRisk-reducing surgery inBRCA-mutation carriers is frequently not cost-covering for the executing hospitals in the German health-care system. Thus, appropriate concepts are required to ensure a nationwide care.
Source: European Journal of Medical Research - Category: Research Source Type: research
More News: Cancer | Cancer & Oncology | Germany Health | Health Management | Mastectomy | Research | Study